Navigation Links
GeneThera - CHANGING DIRECTIONS - an Update to Shareholders
Date:11/3/2008

STEC. The bacteria that make these toxins are called 'Shiga toxin producing' E. coli, or STEC for short." Shiga toxin is one of the most potent toxins known to man, so much so that the Centers for Disease Control and Prevention (CDC) lists it as a potential bioterrorist agent (CDC, n.d.).

ABOUT GENETHERA, INC.

GeneThera, Inc., is a molecular biotechnology company located in Wheat Ridge, Colorado. The Company provides genetic diagnostic solutions for the veterinary and agricultural industries with future plans to include the healthcare industry. The Company's proprietary diagnostic solution is based on a genetic expression assay, GES(TM), a protocol designed to function on a highly automated Fluorogenic PCR platform. This platform enables GeneThera to offer tests that are presently not available from other technologies. The GES is designed for a host of individual diseases, the current priorities being Mad Cow disease, Chronic Wasting Disease, E. coli 0157:H7 and Johne's disease, all diseases affecting cattle worldwide. For more information, contact Dr. Tony Milici at 303-463-6371 or Al Goldsmith of The Goldsmith Group LLC at 303-838-4370.

This press release contains forward-looking statements, which are made pursuant to the Safe-Harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as "intends," "believes," and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, the ability to secure additional sources of finance, the ability to reduce operating expenses, and other factors described in the Company's filings with the Securities and Exchange Commission. The actual results that the Company achieves may differ materially from a
'/>"/>

SOURCE GeneThera, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Changing the way doctors treat high blood pressure
2. Use of intraoperative MRI adds time but care-changing information to neurosurgery, study shows
3. AAPPO and HCAA Form Partnership to Enhance Services to Meet the Changing Business Needs of PPOs and TPAs
4. New DuPont(TM) Agility(TM) SG Herbicide Offers Wheat Growers Answers to Changing Weed Control Needs
5. Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation
6. Fish devastated by sex-changing chemicals in municipal wastewater
7. Lupus Advocates Seek Increased Federal Response to Life-Changing, Life-Threatening Disease Affecting 1.5 Million Americans
8. Freeland, MI Woman Wins $50,000 for Losing Weight, Adding Muscle and Changing Her Life
9. The Changing Face of Medicine: National Medical Fellowships Annual Awards Gala Honors Three Fellows
10. Changing school environment curbs weight gain in children
11. Pennsylvania Health Secretary Focuses on Changing the Climate of Health Care During National Public Health Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Mary Ann Thompson and Mathieu Nikel decided it was time to ... their son, Isaac, said there was only one choice for them ... 2001 when Thompson was an undergraduate student and needed a French ... time, was French and so she asked him. , ... when she was 7 years old. Nikel is originally from ...
(Date:9/18/2014)... Kent, WA Chiropractor Danene Saggau ... to announce that Dawn Kelly has agreed to become the ... looks forward to Ms. Kelly expanding her role within the ... her a key contributor. “ Dawn Kelly brings to ... personal experiences that will allow me to focus on ...
(Date:9/18/2014)... 2014 Memorial Cardiac and Vascular ... week by performing the first ever, adult heart transplant ... for Organ Sharing) approval to launch the adult heart ... two programs in South Florida. , The skilled ... Gongora, Medical Director of the Adult Heart Transplant ...
(Date:9/18/2014)... 18, 2014 (HealthDay News) -- Exposure to diverse communities ... study. Hearing different languages in the park ... to learn from people who are different from them, ... like adults, are often biased against interacting with and ... Amanda Woodward, a University of Chicago psychology professor, said ...
(Date:9/18/2014)... By Steven Reinberg HealthDay ... a sign that the Ebola outbreak in West Africa is starting ... that more than 700 new cases of the deadly viral infection ... number of cases to more than 5,300, with roughly half of ... reported. The number of deaths now tops 2,600. WHO ...
Breaking Medicine News(10 mins):Health News:For The First Time in Over a Decade Mercy College Alumni Marry at College 2Health News:Lake Meridian Chiropractic of Kent, WA Announces that Dawn Kelly Has Been Promoted to the Position of Office Manager 2Health News:Memorial Cardiac & Vascular Institute Performs First Adult Heart Transplant in Broward County 2Health News:Memorial Cardiac & Vascular Institute Performs First Adult Heart Transplant in Broward County 3Health News:Memorial Cardiac & Vascular Institute Performs First Adult Heart Transplant in Broward County 4Health News:Study: Exposure to Diversity Might Boost Baby's Social Skills 2Health News:New Ebola Cases Top 700 in Just One Week, Officials Report 2Health News:New Ebola Cases Top 700 in Just One Week, Officials Report 3
... of low health literacy the difference between patients, ... effectively communicate complex medical information is $106 billion ... biopharmaceutical company. To improve the health literacy of professionals ... health literacy study emphasis beginning this fall. The MU ...
... , ... Government Agencies to Increase ROI of IT Infrastructure , ... Reston, VA (PRWEB) February 18, 2010 -- Carahsoft ... Parabonâ Computation , a veteran provider of extreme-scale grid computing software and services. ...
... ... software standardization program at seven hospital laboratories of the Cleveland Clinic in Ohio. ... ... healthcare diagnostic information technology and outreach solutions, has successfully completed system-wide implementation of ...
... Rat studies suggest Victoza could spur rare thyroid tumor, ... THURSDAY, Feb. 18 (HealthDay News) -- The U.S. Food ... January to approve a new diabetes drug, Victoza (liraglutide), ... risk for a rare thyroid cancer. , Victoza, among ...
... (Feb. 17, 2010) Van Andel Research Institute ... sunitinib, a treatment that is currently the first line of ... form of kidney cancer. Most patients who show a ... after one year of treatment. Kidney cancer is among ...
... , ST. PETERS, Mo. , Feb. 18 ... Electronic Materials, Inc., has donated $25,000 to Meds & ... charity dedicated to saving the lives of Haiti ,s malnourished ... Kids produces peanut-based ready-to-use therapeutic food (RUTF) – known in ...
Cached Medicine News:Health News:MU offers training program to improve health literacy 2Health News:Parabon's Frontier Grid Platform Software Now Available on Carahsoft's GSA Schedule 2Health News:Parabon's Frontier Grid Platform Software Now Available on Carahsoft's GSA Schedule 3Health News:Sunquest Completes System-Wide Implementation at Cleveland Clinic Hospital Laboratories 2Health News:FDA Approved Diabetes Drug Despite Hints at Cancer Risk 2Health News:FDA Approved Diabetes Drug Despite Hints at Cancer Risk 3Health News:VARI findings may help patients with deadly kidney cancer 2Health News:MEMC Foundation Donates to Help Fight Malnourishment in Haiti 2Health News:MEMC Foundation Donates to Help Fight Malnourishment in Haiti 3
(Date:9/18/2014)... Sept. 18, 2014  Zacks.com announces the list of ... Zacks Equity Research analysts discuss the latest news and ... featured in the blog include the Avanir Pharmaceuticals (Nasdaq: ... NPSP - Free Report ), Orexigen (Nasdaq: OREX ... Free Report ) and Gilead (Nasdaq: GILD - ...
(Date:9/18/2014)... DIEGO , Sept. 18, 2014  Halozyme ... announced that the U.S. Food and Drug Administration ... enrollment and dosing of PEGPH20 in SWOG,s ongoing ... designed to evaluate Halozyme,s investigational drug PEGPH20 (PEGylated ... chemotherapy (mFOLFIRINOX) in patients with metastatic pancreatic adenocarcinoma.  ...
(Date:9/18/2014)... After 6 months of careful research ... - the new programme for the next Cool Chain & ... global Cool Chain series, has just been released! ... As the lines between supply chain, logistics, QA and purchasing ... is broad and yet specific, focused and yet accessible, inclusive ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 2The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 3The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 4The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 5The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 6SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 2SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 3SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 4Europe's Biggest and Longest-Running Gathering of Life Sciences Logistics, Supply Chain & QA Professionals 2
... VIEW, Calif., Dec. 21, 2010 MAP Pharmaceuticals, Inc. (Nasdaq: ... ™ open-label safety trial.  The Company has now completed ... (NDA) for LEVADEX and plans to submit an NDA in ... inhaled migraine therapy that has completed Phase 3 clinical development ...
... -- China Botanic Pharmaceutical Inc. (AMEX: CBP ... and distributor of botanical products, bio-pharmaceuticals and traditional Chinese ... considerable progress in its efforts to comply with the ... 404") for fiscal year 2010. As announced ...
Cached Medicine Technology:MAP Pharmaceuticals Announces Completion of LEVADEX™ Open-Label Safety Trial 2MAP Pharmaceuticals Announces Completion of LEVADEX™ Open-Label Safety Trial 3China Botanic Announces Progress on its SOX 404 Compliance Program 2China Botanic Announces Progress on its SOX 404 Compliance Program 3
ELISA Test System for the detection of HBc...
Test for Anti-HBc for use on the Abbott Prism...
... flexible meter for Point of ... Accu-Chek Inform System offers user-friendly, ... the only Point of Care ... the entry and automatic transfer ...
... Introducing BenchMark XT® the only ... the flexibility you need to expand ... and improve your slide turnaround time. ... You choose how to use the ...
Medicine Products: